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ABSTRACT 
 
Introduction of small interfering RNAs (siRNAs) into cells results in transitory silencing of target genes with 
complementary sequence. Incorporating siRNAs into short-hairpin RNAs (shRNAs) or microRNA-adapted 
shRNAs (shRNAmir) is a popular tool for targeted gene silencing. shRNAmirs mimicking endogenous pre-
microRNAs  (unprocessed  hairpin  microRNAs)  are  more  difficult  to  design  and  result  in  longer  RNA 
molecules. The use of microRNA (miRNA) loop sequences in shRNAs as an alternative to an entire pre-
microRNA structure on silencing efficiency has not been studied extensively. This report shows that loop 
sequences derived from native miRNAs improves the efficiency of silencing due to the processing of the 
shRNAs into mature siRNAs. 
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INTRODUCTION 
 
Animal cells  use RNA interference (RNAi) as a natural 
mechanism to regulate gene expression through the use of 
miRNAs.  miRNAs  are  transcribed  from  the  genome  as 
primary  miRNA  transcripts  (pri-miRNA),  which  are 
processed by Drosha into precursor miRNA hairpins (pre-
miRNA: Lee et al, 2003). Exportin-5 transports the hairpin 
from the nucleus into the cytoplasm (Yi et al, 2003) where 
the  loop  of  the  hairpin  precursor  is  removed  by  the 
ribonuclease III enzyme Dicer, leaving the mature 22-25 
nt  double  stranded  miRNA  (Zamore  et  al,  2000).  The 
miRNA guide strand loads into the RNA induced silencing 
complex  (RISC)  which  directs  it  to  the  complementary 
messenger  RNA  (mRNA)  resulting  in  cleavage  of  the 
target  mRNA  (Hammond  et  al,  2000).  Thousands  of 
miRNAs  are  predicted  to  be  present  in  every  cell  and 
many of these miRNAs are highly regulated to be tissue or 
cell cycle specific (Thomson et al, 2006; Obernosterer et 
al,  2006).  The  cellular  RNAi  mechanism  has  been 
successfully  adapted  to  specifically  silence  genes  of 
interest including viral and endogenous genes as reviewed 
in Pushparaj PN and Melendez AJ (2006). 
 
One  method  to  artificially  induce  RNAi  induced  gene 
silencing  is  to  express  shRNAs.  shRNAs  consist  of  a 
siRNA  target  sense  sequence  acting  as  the  5’  stem,  a 
spacer sequence which forms the loop and the anti-sense 
sequence forming the 3’ stem. An alternative method is to 
mimic  naturally  occurring  pri-miRNA  structures 
shRNAmirs (Boden et al, 2004; Siolas et al, 2005). Once 
transcribed  from  an  expression  vector  these  molecules 
enter the RNAi pathway at the Drosha step for shRNAmirs 
or the Dicer step for shRNAs, to be cleaved into siRNAs 
(Henry et al, 2006; Gou et al, 2007). 
 
It has been shown that the shRNA loop sequence is critical 
for  efficient  mRNA  silencing  as  the  majority  of  the  
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processing by Dicer occurs near the loop (McManus et al, 
2002). Initial shRNA expression experiments showed that a 
19  nt  siRNA  sequence  and  a  9  nt  spacer  was  the  most 
efficient  and  this  structure  has  become  the  standard  for 
shRNA  design  (Brummelkamp  et  al,  2002).  The  use  of 
endogenous  miRNA  loop  sequences  to  improve  shRNA 
silencing  has  not  been  extensively  investigated.  To 
determine whether shRNA silencing of viral genes could be 
improved by the use of miRNA loop sequences, shRNAs 
targeting influenza A/PR/8/34 (PR8) strain Nuclear Protein 
(NP)  mRNA  and  chicken  anaemia  virus  (CAV)  mRNA 
were designed. These shRNAs contain 19 nt siRNA target 
sequences with loop sequences derived from one of three 
native  miRNAs  (chicken  miR17,  miR30a  and  human 
miR30a)  known  to  express  highly  in  most  cell  types. 
Silencing was compared to the highly efficient 9 nt loop 
sequence described by Brummelkamp et al, (2002). 
 
MATERIALS AND METHODS 
 
shRNA loop design and plasmid constructs 
shRNAs targeting chicken anaemia virus (CAV) mRNA 
have previously been assayed for silencing against peGFP-
CAV (Hinton  TM and Doran  TJ, in  press).  To produce 
pEGFP-NP, a pGEMTeasy plasmid containing a 180 bp 
fragment of NP was digested with NotI. The NP fragment 
was  gel  purified  and  ligated  into  the  similarly  digested 
pEGFP-C (a gift from David Cummins, CSIRO Livestock 
Industries, Australia). The siRNA sequence targeting NP 
was obtained from Ge et al, (2003). NP shRNA molecules 
were designed with either the 9 nt hairpin loop sequence of 
Brummelkamp  et  al,  (2002)  or  the  microRNA  loop 
sequences  from  human  miR30a  (miRBase  ref: 
MI0000088), chicken miR30a (miRBase ref: MI0001204) 
and chicken miR17 (miRBase ref: MI0001184) obtained 
from  miRBase  (http://microrna.sanger.ac.uk/sequences). 
Complementary  oligonucleotides  were  annealed  and 
ligated into pchU6-4 as described previously (Hinton TM 
and  Doran  TJ,  in  press).  The  forward  oligonucleotide 
sequences used are shown in Table 1 and were obtained 
from Geneworks (Australia). The resulting Influenza PR8 
NP  shRNA  constructs have  been  designated pshNP-OL, 
pshNP-miR17, pshNP-miR30agga and pshNP-miR30ahsp. 
The CAV shRNA constructs have been named pshVP2/3-
1-OL,  pshVP2/3-1-miR17,  pshVP2/3-1-miR30agga, 
pshVP2/3-1-miR30ahsp,  pshVP2/3-3-OL,  pshVP2/3-3-
miR17,  pshVP2/3-3-miR30agga  and  pshVP2/3-3-
miR30ahsp. All constructs were sequenced by Micromon 
DNA sequencing facility (Monash University, Australia). 
 
Cells and virus 
Chicken  fibroblast  cells  (DF1:  ATCC  No.  CRL-12203) 
were grown in DMEM and Madin-Darby canine kidney 
cells  (MDCK:  ATCC  No.  CCL-34)  were  grown  in 
EMEM, both were supplemented with 10% foetal bovine 
serum, 2 mM glutamine, 10 mM Hepes, 1.5 g/l sodium 
bicarbonate,  4.5g/l  glucose,  0.01%  (w/v)  penicillin  and 
0.01% (w/v) streptomycin at 37ºC with 5% (v/v) CO2 and 
sub-cultured twice weekly. 
 
Influenza  A/PR/8/34  (PR8)  strain  virus  stock  was 
produced  by  limiting  dilution  passage  in  the  allantoic 
cavity of 10 day old embryonated chicken eggs at 34°C for 
48-72 hr. Virus was passaged three times.  
 
EGFP-fusion silencing 
DF1 cells were seeded at 1.5x10
5 cells in 24-well tissue 
culture plates in duplicate and  grown  overnight at  37ºC 
with 5% (v/v) CO2. Plasmids were transfected into cells 
using  Lipofectamine  2000  (Invitrogen,  USA)  as  per 
manufacturer’s instructions. Briefly, 1 µg of pEGFP-NP or 
pEGFP-CAV  and  1  µg  of  the  relevant  shRNA  plasmid 
were mixed with 2 µl of Lipofectamine 2000 both diluted 
in 100 µl OPTI-MEM (Invitrogen, USA) and incubated at 
room temperature for 20 min. The DNA:lipofectamine mix 
was added to cells and incubated for 4 hr. Cell media was 
replaced and incubated for 72 hr. Cells were washed twice 
with PBS, trypsinised and washed twice with FACS wash 
(PBS with 1% (v/v) FBS). Cells were subjected to flow 
cytometry  and  EGFP  silencing  was  analysed  as  a 
percentage  of  the  non-silencing  shRNA  mean  EGFP 
(measured on FITC wavelength) fluorescence. 
 
Influenza A-PR8 silencing 
MDCK cells were transfected using Amaxa nucleofector 
electroporation  (Amaxa  Biosystems,  Germany).  Briefly 
1.5x10
6  MDCK  cells  were  pelleted  and  resuspended  in 
100  µl  of  nucleofector  T  solution  with  DNA  and 
electroporated with program T20. Cells were diluted with 
500 µl of prewarmed growth media, aliquoted into 6 wells 
of a 24-well culture plate and incubated overnight at 37ºC 
with 5% (v/v) CO2. Influenza A PR8 virus was serially 
diluted  in  viral  growth  media  (VGM,  with  0.3%  (v/v) 
BSA,  5  µg/ml  trypsin  and  lacking  FCS) and  cells were 
infected at multiplicities of infection (MOI) of 0.01, 0.001, 
0.0001 in duplicate and were incubated at 37ºC for 1 hr, 
virus was replaced with VGM and incubated for 48 hr. 
Supernatant  was  taken  and  used  in  a  haemagglutination 
assay according to the OIE Manual. Briefly, this involved 
serial two-fold dilutions of virus in PBS these were mixed 
with an equal volume of a 0.5% (v/v) chicken erythrocyte 
suspension. After 1 hr incubation at room temperature, the 
HA  titer  was  estimated  by  the  highest  dilution  with 
hemagglutination. 
 
RNA isolation and northern blotting  
DF1 cells were seeded and grown to 80% confluency in 25 
cm  tissue  culture  flasks  (Nunc,  USA).  Plasmids  were 
transfected into the DF1 cells using Lipofectamine 2000. 
Briefly, 12 µg of the relevant shRNA plasmid was mixed 
with  20  µl  of  Lipofectamine  2000  and  transfected  as 
described  previously.  RNA (<200 nt) was purified from 
transfected  cell  cultures  using  mirVanaTM  miRNA 
isolation  kits  (Ambion,  Austin  USA)  and  concentrated 
using  Millipore  microcon  centrifugal  filters  (YM-30; 
Millipore, USA). Approximately  1 µg  of low  molecular 
weight  RNA  was  resolved  on  a  7M  Urea-15%  (w/v) 
polyacrylamide gel and transferred to a positively charged 
membrane (Hybond  plus, Amersham Biosciences, USA) 
using a Trans-blot semi-dry transfer cell (BioRad, USA). 
The efficiency of each hairpin expression and processing 
was  determined  using  the  NP-Locked  Nucleic  Acid  
(LNA)  probe  (5'-CTCCGAAGAAATAAGATCC-3'; 
Sigma-  Proligo,  USA)  that  was  end-labeled  with  [
32γP] 
dATP using 10 U of OptiKinase (USB, USA).  Underlined   
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Table 1:  Forward shRNA oligonuleotide sequences  
Primer Name  Primer sequence 
NP-OL  GGATCTTATTTCTTCGGAGTTCAAGAGACTCCGAAGAAATAAGATCCTTTTTTGGAAGGATCC 
NP-miR17  GGATCTTATTTCTTCGGAGGATATATAGACTCCGAAGAAATAAGATCCTTTTTTGGAAGGATCC 
NP-ggamiR30a  GGATCTTATTTCTTCGGAGCTGTGAAGCAGCAGATGGGGCTCCGAAGAAATAAGATCCTTTTTTGGAAGGATCC 
NP-hspmiR30a  GGATCTTATTTCTTCGGAGCTGTGAAGCCACAGATGGGCTCCGAAGAAATAAGATCCTTTTTTGGAAGGATCC 
CAVVP2/3-1-OL  ATTCGGAATTACAGTCACTCTATTTCAAGAGAATAGAGTGACTGTAATTCCTTTTTTGGAA 
CAVVP2/3-1-miR17  ATTCGGAATTACAGTCACTCTATGATATATAGAATAGAGTGACTGTAATTCCTTTTTTGGAA 
CAVVP2/3-1-ggamiR30a  ATTCGGAATTACAGTCACTCTATCTGTGAAGCAGCAGATGGGGATAGAGTGACTGTAATTCCTTTTTTGGAA 
CAVVP2/3-1-hspmiR30a  ATTCGGAATTACAGTCACTCTACTGTGAAGCCACAGATGGGATAGAGTGACTGTAATTCCTTTTTTGGAA 
CAVVP2/3-3-OL  GAAGGTGTATAAGACTGTATTCAAGAGATACAGTCTTATACACCTTCTTTTTTGGAA 
CAVVP2/3-3-miR17  GAAGGTGTATAAGACTGTAGATATATAGATACAGTCTTATACACCTTCTTTTTTGGAA 
CAVVP2/3-3-ggamiR30a  GAAGGTGTATAAGACTGTACTGTGAAGCAGCAGATGGGGTACAGTCTTATACACCTTCTTTTTTGGAA 
CAVVP2/3-3-hspmiR30a 
shGFP 
GAAGGTGTATAAGACTGTACTGTGAAGCCACAGATGGGTACAGTCTTATACACCTTCTTTTTTGGAA 
GGTGATGCTACATACGGAATTCAAGAGATTCCGTATGTAGCATCACCTTTTTTGGAA 
 
a Letters in bold indicate PollIII promoter termination signal 
b Letters in italics indicate retriction site overhangs for ligation 
c Letters underlined indicate loop sequences 
 
 
nucleotides indicate the locked bases. Hybridization was 
conducted  overnight  at  42
oC  in  50%  (v/v)  formamide, 
0.5% (w/v) SDS, 5x SSPE, 5x Denhardts solution and 100 
µg/ml denatured herring sperm DNA (Roche, USA). The 
membrane  was  washed  3  times  in  2x  SSC,  0.1%  (w/v) 
SDS at 42
oC prior to overnight autoradiographic exposure. 
The  size  of  the  resolved  RNA  was  determined  by 
comparison with AmbionTM Decade markers (Ambion). 
 
RESULTS 
 
Influenza PR8 NP shRNA loop sequences and plasmid 
constructs 
The loop sequences used in this study were obtained from 
either Brummelkamp et al. (2002) or from miRBase. We 
chose the human miR30a loop sequence (miR30ahsp) as 
miR30a based shRNAmirs express high levels of siRNAs 
(Boden, et al, 2004). For silencing chicken pathogens, the 
chicken  miR30a  (miRgga30a)  loop  sequence  was  also 
selected, as it contains two nucleotide differences to the 
human  version.  The  chicken  miR17  (miR17)  loop 
sequence was selected as the native miRNA is expressed 
at high levels in all chicken cell types (ICGSC, 2004). A 
siRNA  targeting  Influenza  NP  was  adapted  to  shRNAs 
containing one of the four loop sequences (Table 1). The 
resulting plasmids are referred to as pshNP-OL, pshNP-
miR17, pshNP-miR30agga and pshNP-miR30ahsp. Figure 
1A describes the predicted structures and ∆G values of the 
original shRNA structure of Brummelkamp et al, (2002) 
and the native microRNAs, whilst the predicted structures 
and ∆G values of the NP hairpins are shown in Figure 1B. 
It  should  be  noted  that  4  of  the  nucleotides  in  the 
Brummelkamp  shRNA  loop  sequence  are  predicted  to 
base-pair. The miR30a shRNA structure predictions and 
∆G values closely resemble those of the native miRNAs, 
missing  one  2  nt  bulge,  whilst  the  miR17  shRNA  loop 
matches the structure predicted for the miRNA, however 
the stem appears quite different as it does not contain the 
multiple bulges. All shRNAs were under the control of the 
chicken  U6-4  promoter  (chU6-4),  along  with  the  non-
silencing (pshNS) and positive (pshEGFP, Table 1) control 
described previously (Wise et al, 2007).  
 
Chicken miR17 loop sequence decreases the ability of 
the  shRNA  to  silence  EGFP-fusion  expression,  by 
inhibiting processing of the hairpin to mature siRNAs 
Prior  to  virus  silencing  experiments,  each  NP  shRNA 
vector was assayed for activity against EGFP-NP fusion 
mRNA in the chicken fibroblast cell line DF1. pshNP-OL 
was highly active at silencing pEGFP-NP mRNA (Figure 
2A). pshNP-miR30agga and pshNP-miR30ahsp showed a 
marginal  increase  in  silencing  pEGFP-NP  compared  to 
pshNP-OL (Figure 2A). Inclusion of the chicken miR17 
loop sequence resulted in a 3-fold decrease in EGFP-NP 
mRNA silencing (Figure 2A).  
 
To determine why pshNP-miR17 was less active than other 
constructs, small RNAs were isolated from transfected DF1 
cells  and  analysed  by  northern  blot  (Figure  2B).  This 
method detects both the hairpin structure and the mature 
siRNA using a probe directed at the NP siRNA sequence. 
Hairpin and mature siRNA  were  detected  for  pshNP-OL   
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Figure 1. Schematic representation of influenza H1 NP targeting shRNAs with different microRNA loops. A: Native pre-miRNAs. 
The red letters are the siRNA sequences, black letters indicate extra miRNA stem sequences, blue letters indicate the loop sequence 
used and underlined letters indicate loop bases not present in the shRNA constructs. B: NP targeting shRNAs with microRNA loops 
predicted through mFOLD. The red letters are the siRNA sequences and the blue letters indicate the loop sequences used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
   A:                    B: 
 
 
Figure 2. A: Silencing of EGFP-NP fusion mRNA by shRNAs in DF1 cells. DF1 cells were co-transfected with 1 µg each of the 
relevant vectors as indicated in X axis and 1µg of pEGFP-NP where required for 72 hr. Cells were then assayed by flow cytometry 
and analysed in Microsoft Excel. Values are shown as percentages of the negative control shRNA (shNS), as the mean of three 
separate experiments in duplicate ±  standard deviation. B: Verification of shRNA and siRNA expression by northern blot. Northern 
blot of NP targeted shRNA molecules.  
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and both miR30a constructs (Figure 2B). The NP miR17 
hairpin  (pshNP-miR17)  was  detected,  but  no  mature 
sequence  was  observed  (Figure  2B).  The  northern  blot 
shows a high level of unprocessed hairpin present from all 
vectors compared to the level of mature siRNAs observed 
(Figure 2B). A higher concentration of mature siRNA was 
present  from  the  miR30a  constructs.  No  bands  were 
observed  in  the  untransfected  or  non-silencing  control 
(Figure 2B).  
 
shRNA silencing of viral RNA mimics the EGFP-fusion 
assay 
The  shRNA  constructs  were  assayed  for  the  ability  to 
silence  Influenza  A  strain  PR8  in  MDCK  cells.  The 
haemagglutination assay showed consistent results to the 
EGFP reporter assay with highly efficient knockdown of 
virus replication observed with the original loop construct 
(Figure  3).  The  miR30a  loop  sequences  increased  the 
silencing  ability  of  the  NP  siRNA  at  the  highest 
concentration  of  virus,  with  the  chicken  miR30a  loop 
giving  the  best  knockdown  (Figure  3).  As  expected, 
pshNP-miR17  was  unable  to  inhibit  viral  replication 
efficiently. 
 
Different loop sequences do not improve less efficient 
siRNA molecules 
To determine if the loop sequence affected the silencing 
ability  of  other  shRNA  sequences,  vectors  expressing 
shRNAs with the four different loop sequences targeting 
chicken  anaemia  virus  mRNA  were  produced.  Two 
shRNA  sequences  were  analysed,  one  highly  active 
against  EGFP-CAV  fusion  mRNA  (pshVP2/3-1)  and 
another less active sequence (pshVP2/3-3; Hinton TM and 
Doran TJ, in press). The resulting constructs are referred 
to  as  pshVP2/3-1-OL,  pshVP2/3-1-miR17,  pshVP2/3-1-
miR30agga,  pshVP2/3-1-miR30ahsp,  pshVP2/3-3-OL, 
pshVP2/3-3-miR17,  pshVP2/3-3-miR30agga  and 
pshVP2/3-3-miR30ahsp.  The  same  non-silencing  control 
(pshNS)  and  EGFP  targeted  shRNA  (pshGFP)  were 
utilised. Similar silencing results to those observed with 
the  NP  shRNAs  were  obtained  for  the  CAV  shRNA 
contructs in the DF1 GFP reporter assay (Figure 4). The 
shRNAs  containing  the  miR17  loop  sequence  were  less 
active, whilst the chicken miR30a loop shRNAs was the 
most  efficient  (Figure  4,  A  and  B).  Interestingly,  the 
different loop sequences examined were unable to improve 
the  activity  of  shVP2/3-3,  indicating  that  whilst  a  loop 
sequence can improve hairpin processing, they are unable 
to improve the ability of a siRNA to silence the target gene 
(Figure 4B). 
 
DISCUSSION 
 
shRNAmirs  are  processed  by  Drosha  into  shRNAs.  
shRNAs are then recognized and processed into siRNAs 
by  Dicer  (Paddison  et  al,  2002).  Initially  shRNAmirs 
appeared  to  produce  more  mature  siRNAs  resulting  in 
better  silencing  (Boden  et  al,  2004;  Silva  et  al,  2005). 
However, McManus et al, (2002) has shown that the loop 
sequence is the most critical region in recognition of the 
shRNA for processing. To determine if a native miRNA 
loop  sequence  could  improve  shRNA  processing  and 
increase  silencing,  a  comparison  of  shRNAs  containing 
either  the  commonly  used  9nt  loop  sequence  from 
(Brummelkamp et al, 2002) and three endogenous miRNA 
loop sequences was performed.  
 
The miR17 loop sequence used in this study was selected 
based on the unpaired nucleotides in the predicted miRNA 
structure. Subsequent analysis of chicken miR17 sequence 
revealed  four  additional  bases  extend  3’  from  the  loop 
sequence, two of which are base-paired with the siRNA 
(miRBase,  Figure  1A).  Chicken  miR17  also  contains 
several  bulges  in  the  stem  sequence  not  present  in  the 
shRNAs,  resulting  in  the  shRNA  predicted  structure 
looking different (Figure 1B). Little is known about the 
shRNA  structure  requirement  for  Dicer  cleavage. 
McManus  et  al,  (2002)  has  demonstrated  that  the 
processing  of  shRNAmirs  was  sensitive  to  structural 
modifications including bulge position and loop sequence. 
The  absence  of  the  bulges  in  miR17  stem  may  have 
contributed to the inefficient shRNA processing. It would 
be interesting to test a NP-miR17 based shRNAmir with 
the bulges and paired loop sequence incorporated to see if 
processing  is  restored.  The  miR30a  shRNA  constructs, 
despite  missing  a  2nt  bulge  in  the  stem  mimic  the 
endogenous miRNA more accurately resulting in correct 
recognition  and  processing  (Figure  1B).  Therefore  it 
appears important to choose loop sequences that will result 
in an shRNA that closely mimics the endogenous miRNA 
structure for improved silencing.  
 
Although  chicken  miR17  is  highly  and  ubiquitously 
expressed in chicken cells (ICGSC, 2004), it is transcribed 
from  the  miR17-92  miRNA  cluster  which  produces  6 
miRNAs.  One  of  these,  miR18a  is  known  to  require  a 
cellular protein, the nucleo-cytoplasmic shuttling  protein 
hnRNP A1, to be processed (Guil and Caceres, 2007). No 
similar  factor  has  been  determined  for  miR17,  however 
this  could  explain  the  inefficiency  of  miR17  shRNA’s 
processing.  Understanding  the  factors  that  regulate 
processing of shRNAs containing miRNA loop sequences 
would be advantageous in many circumstances. It could 
lead to targeted expression of the shRNA within cells or 
tissues, however, further studies are required in this area.  
 
A recent paper by  Liu, et al (2008)  used the  miR17-92 
cluster  as  a  backbone  for  expressing  multiple  siRNAs 
targeting HIV. The HIV siRNA expressed from the miR17 
position  gave  minimal  silencing  as  a  single  hairpin 
transcript,  however  silencing  efficiency  increased  when 
the siRNA was present in a polycistronic transcript. The 
difference  in  silencing  was  thought  to  be  due  to  mis-
folding of the hairpin and decreased processing to mature 
siRNA when present singly. Therefore   the use  of loop 
sequences  from  polycistronic  miRNAs  may  be 
problematic. 
 
CONCLUSIONS 
 
This  study  indicates  that  endogenous  miRNA  loop 
sequences  that  are  derived  from  the  animal  host  of  the 
target virus can increase the efficiency of mature siRNA 
production.  However  the  choice  of  the  loop  sequences 
requires careful consideration of the miRNA it is obtained   
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Figure 3. Silencing of influenza A PR8 by shRNAs in MDCK cells. MDCK were electroporated with 2.5 µg of DNA in 
nucleofector solution T with Amaxa program T20. Plasmids used are indicated in X axis. Transfected cells were incubated for 24 h 
then infected with Influenza A PR8 virus for 48 h.  Supernatants were assayed for Influenza A virus by HA assay. Graph depicts two 
separate experiments in duplicate ± SEM. 
 
 
 
 
A: 
 
 
 
 
 
 
 
 
 
 
 
 
 
B: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Silencing of targeted EGFP-CAV fusion mRNA by shRNAs in DF1 cells. A. DF1 cells were co-transfected with 1 µg each 
of the relevant pshVP2/3-1 vectors as indicated in X axis and 1µg of pEGFP-CAV where required for 72h. B. DF1 cells were co-
transfected with 1 µg each of the relevant pshVP2/3-3 vectors as indicated in X axis and 1µg of pEGFP-CAV for 72 hr. Cells were 
then assayed by flow cytometry and analysed in Microsoft Excel. Values are shown as percentages of the non-silencing control 
shRNA (shNS), as the mean of three separate experiments in duplicate ± standard deviation.
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from.  In  the  future,  understanding  the  efficiency  and 
specificity of miRNA loop sequences may prove useful for 
delivering tissue targeted gene silencing in either single or 
multiple expression constructs. 
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miRNA: MicroRNA  
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RISC: RNA induced silencing complex 
siRNA: Small interfering RNA 
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